Acacia Pharma Ltd

General

Total Cases1
Active Cases1
Patents15
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
01/03/25
Summons Issued as to Galenicum Health S.L.U. on 1/3/2025. (mrr) (Entered: 01/03/2025)
01/03/25
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Humanwell Healthcare (Group) Co., Ltd. for PAION UK Limited filed by PAION UK Limited. (mrr) (Entered: 01/03/2025)
01/03/25
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eagle Pharmaceuticals, Inc. for Acacia Pharma Limited filed by Acacia Pharma Limited, Eagle Pharmaceuticals, Inc. (mrr) (Entered: 01/03/2025)
01/03/25
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,561,236; 9,827,251. (mrr) (Entered: 01/03/2025)
01/03/25
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/21/2024. Date of Expiration of Patent: 9,561,236 Expiration date: 04/30/2033 and 9,827,251 Expiration date: 01/13/2034.Thirty Month Stay Deadline: 5/21/2027. (mrr) (Entered: 01/03/2025)
01/03/25
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 01/03/2025)
01/03/25
COMPLAINT for Patent Infringement against Galenicum Health S.L.U. (Filing fee $ 405, receipt number ADEDC-4582389) - filed by PAION UK Limited, Acacia Pharma Limited, Eagle Pharmaceuticals, Inc. (Attachments: # [1] Exhibits A-B, # [2] Civil Cover Sheet)(mrr) (Entered: 01/03/2025)